595 Burrard Street
Vancouver, BC V7X 1L4
Canada
https://www.sironabiochem.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Howard J. Verrico M.D., Ph.D. | Founder, Chairman, CEO & Sec. | 161.28k | N/A | 1961 |
Mr. Christopher D. Hopton C.G.A., CPA | CFO & Director | 147.84k | N/A | 1966 |
Dr. Géraldine Deliencourt-Godefroy Ph.D. | Chief Scientific Officer & Director | 213.39k | N/A | N/A |
Ms. Michelle Seltenrich MBA | VP of Operations | N/A | N/A | N/A |
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.
Sirona Biochem Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.